Oxomemazine is an antitussive agent belonging to the phenothiazine class, primarily utilized for the temporary relief of dry, non-productive coughs associated with respiratory tract infections. This category… Read more








Oxomemazine is an antitussive agent belonging to the phenothiazine class, primarily utilized for the temporary relief of dry, non-productive coughs associated with respiratory tract infections. This category encompasses the active pharmaceutical ingredient, its hydrochloride salt, and a range of related compounds essential for pharmaceutical research and rigorous quality control. Analytical laboratories rely on these high-quality reference standards, including identified process-related impurities such as N-oxide and nitroso derivatives, to perform accurate impurity profiling and method validation. Furthermore, stable isotope labelled compounds of Oxomemazine serve as critical internal standards in mass spectrometry-based assays, enabling precise quantification of the drug and its metabolites in complex matrices. Access to these characterized standards supports comprehensive stability testing, regulatory compliance, and the development of robust analytical procedures throughout the drug development lifecycle.